Abstract
This review covers the 2003-2012 literature data published for natural products originating from marine red algae. The focus is on new antitumour substances, together with details related to the organism sourced. It emphasises 14 promising compounds (isolated from 13 species) whose chemical structures are briefly discussed.
Keywords: Antitumour activity, marine red algae, natural products, novel leads, SAR studies.
Mini-Reviews in Medicinal Chemistry
Title:New Antitumour Natural Products from Marine Red Algae: Covering the Period from 2003 to 2012
Volume: 15 Issue: 9
Author(s): Boris Pejin, Katarina K. Jovanovic and Aleksandar G. Savic
Affiliation:
Keywords: Antitumour activity, marine red algae, natural products, novel leads, SAR studies.
Abstract: This review covers the 2003-2012 literature data published for natural products originating from marine red algae. The focus is on new antitumour substances, together with details related to the organism sourced. It emphasises 14 promising compounds (isolated from 13 species) whose chemical structures are briefly discussed.
Export Options
About this article
Cite this article as:
Pejin Boris, K. Jovanovic Katarina and G. Savic Aleksandar, New Antitumour Natural Products from Marine Red Algae: Covering the Period from 2003 to 2012, Mini-Reviews in Medicinal Chemistry 2015; 15 (9) . https://dx.doi.org/10.2174/1389557515666150511152251
DOI https://dx.doi.org/10.2174/1389557515666150511152251 |
Print ISSN 1389-5575 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5607 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Advances in Transient Receptor Potential Vanilloid-2 Channel Expression and Function in Tumor Growth and Progression
Current Protein & Peptide Science Anti-Tumor Monoclonal Antibodies in Conjunction with β-Glucans: A Novel Anti- Cancer Immunotherapy
Current Medicinal Chemistry Identification of Antifungal Agents Using Combinatorial Approach: An Overview$
Current Medicinal Chemistry - Anti-Infective Agents A Novel Class of Emerging Anticancer Compounds: Oxyprenylated Secondary Metabolites from Plants and Fungi
Current Medicinal Chemistry A New 4-phenyl-1,8-naphthyridine Derivative Affects Carcinoma Cell Proliferation by Impairing Cell Cycle Progression and Inducing Apoptosis
Anti-Cancer Agents in Medicinal Chemistry Nitric Oxide: State of the Art in Drug Design
Current Medicinal Chemistry Testosterone Supplementation on Sarcopenia Components in Chronic Patients: A Systematic Review and Meta-Analysis
Current Pharmaceutical Design Epidemiology and Prevention of Viral Infections in Patients with Hematologic Malignancies
Infectious Disorders - Drug Targets Heterologous Expression and Application of Multicopper Oxidases from <i>Enterococcus</i> spp. for Degradation of Biogenic Amines
Protein & Peptide Letters To Be-et, or Not to Be-et, That is the Question: The Role(s) of Nitrate and Nitrite in Health and Illness
Reviews on Recent Clinical Trials Dietary Polyphenols for Prostate Cancer Therapy
Current Bioactive Compounds Signs and Related Mechanisms of Ethanol Hepatotoxicity
Current Drug Abuse Reviews Emerging Roles of MicroRNA-22 in Human Disease and Normal Physiology
Current Molecular Medicine In vivo behavior and Safety of Lapatinib-Incorporated Lipid Nanoparticles
Current Pharmaceutical Biotechnology Editorial (Thematic Issue: Mechanistic Biomarkers: The Field for the Development of Non-Pharmaceutical and Pharmaceutical Approaches to Diagnostics, Prevention and Treatment of Chronic Diseases)
Current Pharmaceutical Design Magnetic Materials for the Selective Analysis of Peptide and Protein Biomarkers
Current Medicinal Chemistry TRAIL: A Sword for Killing Tumors
Current Medicinal Chemistry Insulin Decreases Therapeutic Efficacy in Colon Cancer Cell Line HT29 Via the Activation of the PI3K/Akt Pathway
Current Drug Discovery Technologies Targeting HOTAIR induces mitochondria related apoptosis and inhibits tumor growth in head and neck squamous cell carcinoma in vitro and in vivo.
Current Molecular Medicine Marine Derived Anticancer Drugs Targeting Microtubule
Recent Patents on Anti-Cancer Drug Discovery